Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease

BACKGROUND AND PURPOSE: There is some controversy regarding heterozygous mutations of the gene encoding parkin (PARK2) as risk factors for Parkinson's disease (PD), and all previous studies have been performed in non-Asian populations. Dosage mutation of PARK2, rather than a point mutation or s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Min Kyung, Kim, Won Chan, Choi, Jung Mi, Hong, Jeong-Hoon, Kang, Suk Yun, Ma, Hyeo-Il, Kim, Yun Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101102/
https://www.ncbi.nlm.nih.gov/pubmed/25045378
http://dx.doi.org/10.3988/jcn.2014.10.3.244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101102/
https://www.ncbi.nlm.nih.gov/pubmed/25045378
http://dx.doi.org/10.3988/jcn.2014.10.3.244

Ejemplares similares